3 ms·
We really could get more out of this data through international collaboration and through linked data (e.g. URIs for columns). See: "Open, and Linked, FDA data"
by westurner 7y ago
We really could get more out of this data through international collaboration and through linked data (e.g. URIs for columns). See: "Open, and Linked, FDA data"
https://github.com/FDA/openfda/issues/5#issuecomment-539296649 https://github.com/FDA/openfda/issues/5#issuecomment-5392966... and "ENH: Adverse Event Count / 'Use' Count Heatmap" https://github.com/FDA/openfda/issues/49 https://github.com/FDA/openfda/issues/49
With sales/usage counts, we'd have a denominator with which we could calculate relative hazard.